会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • Biocompatible polymer compositions for dual or multi staged curing
    • 用于双阶段或多阶段固化的生物相容性聚合物组合物
    • US20050197422A1
    • 2005-09-08
    • US11070217
    • 2005-03-03
    • Roshan MayadunneRaju AdhikariPathiraja Gunatillake
    • Roshan MayadunneRaju AdhikariPathiraja Gunatillake
    • A61K6/00A61K6/087A61L24/04A61L27/18A61L31/06C08G18/10C09J167/07C09J175/16
    • C08G18/10C08G18/3206C08G18/4277C08G18/428C08G18/4854C08G18/7671C08G18/771C08G18/8116C08L75/16C08L101/16
    • The present invention provides a biocompatible polymer composition for use in biomedical applications comprising a base molecule, a linker molecule and at least one initiator compound, said base molecule having at least two differing functionalities, and said linker molecule having a functionality reactive with at least one functionality of said base molecule, the first of said at least two functionalities of said base molecule enabling a first curing stage of said polymer composition by reaction with said linker molecule, and the second and any further functionality of said base molecule enabling second and further curing stages of said polymer composition, said first, second and any further curing stages being capable of activation simultaneously or independently of each other as required. The invention further provides uses of the polymer compositions of the invention in biomedical applications such as tissue engineering, dry delivery, as a bioadhesive in wound healing, as bone substitutes or scaffolds, as cements in dental and periodontal applications and as anti-adhesives or protective barriers.
    • 本发明提供了用于生物医学应用的生物相容性聚合物组合物,其包含基础分子,连接分子和至少一种引发剂化合物,所述碱基分子具有至少两个不同的官能团,并且所述连接分子具有与至少一个 所述碱基分子的功能性,所述碱基分子的所述至少两个官能团中的第一个能够通过与所述连接分子的反应来实现所述聚合物组合物的第一固化阶段,并且所述碱基分子的第二和任何其它官能团能够进行第二次和进一步固化 所述聚合物组合物的阶段,所述第一,第二和任何其它固化阶段能够根据需要同时或彼此独立地活化。 本发明进一步提供本发明的聚合物组合物在生物医学应用中的用途,例如组织工程,干燥递送,作为伤口愈合中的生物粘合剂,作为骨替代物或支架,用作牙科和牙周应用中的水泥,以及作为抗粘合剂或保护性 障碍
    • 7. 发明授权
    • Polyurethane or polyurethane-urea elastomeric compositions
    • 聚氨酯或聚氨酯 - 脲弹性体组合物
    • US5393858A
    • 1995-02-28
    • US962799
    • 1993-02-23
    • Gordon F. MeijsEzio RizzardoArthur BrandwoodPathiraja GunatillakeKlaus H. Schindhelm
    • Gordon F. MeijsEzio RizzardoArthur BrandwoodPathiraja GunatillakeKlaus H. Schindhelm
    • A61L27/00A61L17/04A61L27/18A61L29/00A61L29/06A61L31/00C08G18/10C08G18/48C08G18/65C08G18/66C08G18/76C08G18/30
    • C08G18/765A61L17/04A61L27/18A61L29/06C08G18/10C08G18/4858
    • A polyurethane or polyurethane-urea elastomeric composition, characterized in that the composition is a reaction product of:(A) a soft segment macrodiol which is either:(i) a homopolymer represented by formula I,HO--[(CH.sub.2).sub.n O].sub.m --H Iwherein n represents an integer greater than 5 and less than 13, m is a number such that the number average molecular weight of the compound of formula I falls in the range from 218 to 5000 and optionally at least one hydrogen atom represented in formula I is substituted by a C.sub.1 to C.sub.3 alkyl group or a halogen atom;(ii) a copolymer containing at least 25% by mass of repeating units --(CH.sub.2).sub.n O-- wherein n is as defined in formula I above; or(iii) mixture of macrodiols comprising greater than 10% of a macrodiol as defined in formula I above;(B ) an aliphatic or aromatic diisocyanate known in the art of polyurethane manufacture; and(C) optionally a chain extender.A biomaterial and a medical device which are composed wholly or partly of the polyurethane or polyurethane-urea elastomeric composition are also described.
    • PCT No.PCT / AU91 / 00270 Sec。 371日期:1993年2月23日 102(e)1993年2月23日PCT PCT 1991年6月26日PCT公布。 出版物WO92 / 日本1992年1月9日。一种聚氨酯或聚氨酯 - 脲弹性体组合物,其特征在于所述组合物是以下物质的反应产物:(A)软段大分子二醇,其为:(i)由式I表示的均聚物,HO- [(CH 2)n O] m-HI其中n表示大于5且小于13的整数,m是使式I化合物的数均分子量在218至5000的范围内的数, 式I中表示的至少一个氢原子被C1至C3烷基或卤素原子取代; (ii)含有至少25质量%的重复单元 - (CH 2)n O-的共聚物,其中n如上述式I中所定义; 或(iii)包含大于10%上述式I定义的大分子二醇的大分子二醇的混合物; (B)聚氨酯制造领域已知的脂族或芳族二异氰酸酯; 和(C)任选的扩链剂。 还描述了全部或部分由聚氨酯或聚氨酯 - 脲弹性体组合物组成的生物材料和医疗装置。
    • 8. 发明申请
    • Polymer Compositions for Dual or Multi Staged Curing
    • 双组分或多分段固化的聚合物组合物
    • US20070225387A1
    • 2007-09-27
    • US10591606
    • 2005-03-03
    • Roshan MayadunnePathiraja GunatillakeRaju Adhkari
    • Roshan MayadunnePathiraja GunatillakeRaju Adhkari
    • C08G18/10C09D167/07C09D175/16C09J167/07C09J175/16
    • C08G18/10C08G18/3206C08G18/4277C08G18/428C08G18/4854C08G18/7664C08G18/771C08G18/775C08G18/8025C08G18/8116C08G18/42
    • The present invention provides a polymer composition for use at least in surface coating applications and in fabrication of rigid foams with load bearing capacity comprising a base molecule, a linker molecule and at least one initiator compound, said base molecule having at least two differing functionalities, and said linker molecule having a functionality reactive with at least one functionality of said base molecule, the first of said at least two functionalities of said base molecule enabling a first curing stage of said polymer composition by reaction with said linker molecule, and the second and any further functionality of said base molecule enabling second and further curing stages of said polymer composition, said first, second and any further curing stages being capable of activation simultaneously or independently of each other as required. A further provides uses of the polymer compositions of the invention in surface coating and adhesives applications and in the preparation of rigid foams with load bearing capacity.
    • 本发明提供一种聚合物组合物,其用于至少在表面涂覆应用中并用于制造具有承载能力的刚性泡沫体,其具有包含基础分子,连接分子和至少一种引发剂化合物,所述碱基分子具有至少两个不同的官能团, 并且所述连接分子具有与所述碱基分子的至少一个官能度反应的官能度,所述碱基分子的所述至少两个官能团中的第一个能够通过与所述连接分子的反应来实现所述聚合物组合物的第一固化阶段, 所述基础分子的任何另外的功能使得所述聚合物组合物的第二和进一步固化阶段,所述第一,第二和任何其它固化阶段能够根据需要同时或彼此独立地活化。 本发明的聚合物组合物进一步提供了表面涂层和粘合剂应用以及制备具有承载能力的刚性泡沫的用途。